[68Ga]PSMA

DRUG2 trials

Sponsors

University Hospitals Cleveland Medical Center, Memorial Sloan Kettering Cancer Center

Conditions

Bladder CancerProstate Cancer

Phase 1

A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Cancer

RecruitingNCT05562791

Memorial Sloan Kettering Cancer CenterBladder Cancer

Start: 2022-09-28End: 2027-09-01Target: 20Updated: 2026-04-22

Unknown Phase

Digital PET/CT Using [Ga-68]PSMA vs. [F-18]NaF for Evaluation of Osseous Metastatic Involvement in Prostate Cancer Patients

CompletedNCT05527483

University Hospitals Cleveland Medical CenterProstate Cancer

Start: 2022-04-21End: 2022-10-10Updated: 2024-05-16